Literature DB >> 1316841

Neuropeptide Y. Optimized solid-phase synthesis and conformational analysis in trifluoroethanol.

D F Mierke1, H Dürr, H Kessler, G Jung.   

Abstract

The 36-amino-acid neuropeptide Y (human), which is one of the most potent vasoconstrictors and which exhibits a number of other biological functions, has been synthesized using automated peptide synthesis. The optimized method, using 9-fluorenylmethoxycarbonyl protecting and single-step coupling, yielded the crude product in 90% purity allowing for single-step reversed-phase HPLC purification to greater than 98% purity and a high overall yield (50%). The hormone was characterized by several chromatographic methods, ion-spray mass spectroscopy and Edman degradation. The conformation of human neuropeptide Y was examined by CD, NMR and computer simulations. The CD measurements in trifluoroethanol/water (9:1) show a large percentage of alpha-helix. Variation of concentration, from 0.5 microM increasing up to the 1 mM used for NMR measurements, indicates no evidence for aggregation. In the same solvent system, the NMR line widths were very broad and therefore the resonance assignment was achieved with the exclusive use of two-dimensional NOE spectra. The 248 clearly distinguishable NOEs from the NMR study were used in distance geometry calculations and the resulting structures were refined with restrained molecular dynamics. The results indicate an alpha-helix extending from Arg19 to Gln34. For the N-terminal half of the molecule no regular structure was observed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316841     DOI: 10.1111/j.1432-1033.1992.tb16899.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Peptide conformation in gas phase probed by collision-induced dissociation and its correlation to conformation in condensed phases.

Authors:  Zhongqi Zhang; Joseph Bordas-Nagy
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-03       Impact factor: 3.109

2.  Characterization the effects of structure and energetics of intermolecular interactions on the oligomerization of peptides in aqueous 2, 2, 2-trifluoroethanol via circular dichroism and nuclear magnetic resonance spectroscopy.

Authors:  Chang-Shin Lee; Wei-Cheng Tung; Wan-Chi Luo
Journal:  Protein J       Date:  2012-03       Impact factor: 2.371

3.  Solution structure of human neuropeptide Y.

Authors:  S A Monks; G Karagianis; G J Howlett; R S Norton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

4.  Conformational analysis of neuropeptide Y-[18-36] analogs in hydrophobic environments.

Authors:  E Lazoura; I Maidonis; E Bayer; M T Hearn; M I Aguilar
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

5.  The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold.

Authors:  Andrea Bettio; Michaela C Dinger; Annette G Beck-Sickinger
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

6.  Solution structure by 1H and dynamics by natural abundance 13C NMR of a receptor recognising peptide derived from a C-terminal fragment of neuropeptide Y.

Authors:  K Arvidsson; J Jarvet; P Allard; A Ehrenberg
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.